Analysts think ICLR stock price could increase by 53%
Apr 04, 2025, 11:25 AM
-12.68%
What does ICLR do
ICON plc is a Dublin-based clinical research organization providing outsourced development services to pharmaceutical, biotechnology, and medical device industries, employing 41,100 people. Their specialized services expedite the market entry of new drugs and devices.
20 analysts think ICLR stock price will increase by 52.69%. The current median analyst target is $249.90 compared to a current stock price of $163.67. The lowest analysts target is $193.92 and the highest analyst target is $304.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
